Kraj: Wielka Brytania
Język: angielski
Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)
Fluconazole
Milpharm Ltd
J02AC01
Fluconazole
150mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05020100; GTIN: 8901175007493
FRONT F.I. BACK F.I. Format: 160X600MM | Weight: 50GR RESERVED FOR THE CODE GENERIS FARMACÊUTICA RESERVED ARTICLE NUMBER GENERIS FARMACÊUTICA TEXT AREA 40mm 40mm PACKAGE LEAFLET: INFORMATION FOR THE USER FLUCONAZOLE 50 MG CAPSULES, HARD FLUCONAZOLE 100 MG CAPSULES, HARD FLUCONAZOLE 150 MG CAPSULES, HARD FLUCONAZOLE 200 MG CAPSULES, HARD Fluconazole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Fluconazole is and what it is used for 2. What you need to know before you take Fluconazole 3. How to take Fluconazole 4. Possible side effects 5. How to store Fluconazole 6. Contents of the pack and other information 1. WHAT FLUCONAZOLE IS AND WHAT IT IS USED FOR Fluconazole is one of a group of medicines called “antifungals”. The active substance is fluconazole. Fluconazole is used to treat infections caused by fungi and may also be used to stop you from getting a candidal infection. The most common cause of fungal infections is a yeast called _Candida_. ADULTS You might be given this medicine by your doctor to treat the following types of fungal infections: - Cryptococcal meningitis – a fungal infection in the brain - Coccidioidomycosis – a disease of the bronchopulmonary system - Infections caused by _Candida _and found in the blood stream, body organs (e.g. heart, lungs) or urinary tract - Mucosal thrush - infection affecting the lining of the mouth, throat and denture sore mouth - Genital thrush – infection of the vagina or penis - Skin infections - e.g. athlete’s foot, ringw Przeczytaj cały dokument
OBJECT 1 FLUCONAZOLE 150 MG CAPSULES Summary of Product Characteristics Updated 24-Aug-2022 | Aurobindo Pharma - Milpharm Ltd. • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Fluconazole 150 mg capsules, hard 2. Qualitative and quantitative composition Each capsule, hard contains 150 mg fluconazole. Excipient with known effect: 151.68 mg lactose/hard capsule For the full list of excipients, see section 6.1 3. Pharmaceutical form Capsules, hard Size '1' hard gelatin capsule filled with white to off-white powder and imprinted with 'FL' on white to off- white opaque cap and '150' on white to off-white opaque body with yellow ink. 4. Clinical particulars 4.1 Therapeutic indications Fluconazole is indicated in the following fungal infections (see section 5.1). Fluconazole is indicated in adults for the treatment of: • Cryptococcal meningitis (see section 4.4). • Coccidioidomycosis (see section 4.4). • Invasive candidiasis. • Mucosal candidiasis including oropharyngeal Przeczytaj cały dokument